LCDActive
Coenzyme Q10 (CoQ10)
L37126
Effective: February 6, 2025
Updated: December 31, 2025
Policy Summary
Serum or other body fluid testing for Coenzyme Q10 (CoQ10/ubiquinone) is non-covered for all diseases and clinical indications. Although there are anecdotal reports of benefit in rare mitochondrial encephalomyopathies, the policy considers the indications and testing methodologies controversial and does not provide coverage; claims for CoQ10 testing should be denied.
Coverage Criteria Preview
Key requirements from the full policy
"Serum or other body fluid testing for Coenzyme Q10 (CoQ10, ubiquinone, ubidecarenone) is not covered for any disease or clinical indication."
Sign up to see full coverage criteria, indications, and limitations.